|
|
Article: Alanine aminotransferase depicts treatment efforts for chronic hepatitis C.
- Article from:
- Biotech Week
- Article date:
- September 24, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 SEP 24 - (NewsRx.com & NewsRx.net) -- Alanine aminotransferase depicts treatment efforts for chronic hepatitis C.
"Studies of the kinetics of hepatitis C virus (HCV) decline during interferon (IFN)-based therapy have led to insights into treatment efficacy. However, the kinetics of serum alanine aminotransferase (ALT), an enzyme used as a surrogate of liver damage, have not been closely monitored, and it is not known if they correlate with those of HCV RNA. Here we describe the associations between ALT and HCV dynamics," scientists in the United States report.
"We analyzed 35 patients treated daily with 10 mIU IFN-alpha2b with or without ribavarin ...